Application of Nanopore Sequencing in the Diagnosis and Treatment of Pulmonary Infections
- PMID: 37563539
- PMCID: PMC10590290
- DOI: 10.1007/s40291-023-00669-8
Application of Nanopore Sequencing in the Diagnosis and Treatment of Pulmonary Infections
Abstract
This review provides an in-depth discussion of the development, principles and utility of nanopore sequencing technology and its diverse applications in the identification of various pulmonary pathogens. We examined the emergence and advancements of nanopore sequencing as a significant player in this field. We illustrate the challenges faced in diagnosing mixed infections and further scrutinize the use of nanopore sequencing in the identification of single pathogens, including viruses (with a focus on its use in epidemiology, outbreak investigation, and viral resistance), bacteria (emphasizing 16S targeted sequencing, rare bacterial lung infections, and antimicrobial resistance studies), fungi (employing internal transcribed spacer sequencing), tuberculosis, and atypical pathogens. Furthermore, we discuss the role of nanopore sequencing in metagenomics and its potential for unbiased detection of all pathogens in a clinical setting, emphasizing its advantages in sequencing genome repeat areas and structural variant regions. We discuss the limitations in dealing with host DNA removal, the inherent high error rate of nanopore sequencing technology, along with the complexity of operation and processing, while acknowledging the possibilities provided by recent technological improvements. We compared nanopore sequencing with the BioFire system, a rapid molecular diagnostic system based on polymerase chain reaction. Although the BioFire system serves well for the rapid screening of known and common pathogens, it falls short in the identification of unknown or rare pathogens and in providing comprehensive genome analysis. As technological advancements continue, it is anticipated that the role of nanopore sequencing technology in diagnosing and treating lung infections will become increasingly significant.
© 2023. The Author(s).
Conflict of interest statement
The authors FX and JC have no conflicts of interest that are directly relevant to the content of this article.
Figures
Similar articles
-
A dual-process of targeted and unbiased Nanopore sequencing enables accurate and rapid diagnosis of lower respiratory infections.EBioMedicine. 2023 Dec;98:104858. doi: 10.1016/j.ebiom.2023.104858. Epub 2023 Nov 4. EBioMedicine. 2023. PMID: 37925777 Free PMC article.
-
Clinical value of metagenomic next-generation sequencing by Illumina and Nanopore for the detection of pathogens in bronchoalveolar lavage fluid in suspected community-acquired pneumonia patients.Front Cell Infect Microbiol. 2022 Sep 27;12:1021320. doi: 10.3389/fcimb.2022.1021320. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36237436 Free PMC article.
-
Application of Nanopore Sequencing Technology in the Clinical Diagnosis of Infectious Diseases.Biomed Environ Sci. 2022 May 20;35(5):381-392. doi: 10.3967/bes2022.054. Biomed Environ Sci. 2022. PMID: 35676809 Review.
-
Oxford nanopore sequencing in clinical microbiology and infection diagnostics.Brief Bioinform. 2021 Sep 2;22(5):bbaa403. doi: 10.1093/bib/bbaa403. Brief Bioinform. 2021. PMID: 33483726 Review.
-
Metagenomic identification of severe pneumonia pathogens in mechanically-ventilated patients: a feasibility and clinical validity study.Respir Res. 2019 Nov 27;20(1):265. doi: 10.1186/s12931-019-1218-4. Respir Res. 2019. PMID: 31775777 Free PMC article.
Cited by
-
Bacterial enrichment prior to third-generation metagenomic sequencing improves detection of BRD pathogens and genetic determinants of antimicrobial resistance in feedlot cattle.Front Microbiol. 2024 May 8;15:1386319. doi: 10.3389/fmicb.2024.1386319. eCollection 2024. Front Microbiol. 2024. PMID: 38779502 Free PMC article.
-
Enhancing Clinical Utility: Utilization of International Standards and Guidelines for Metagenomic Sequencing in Infectious Disease Diagnosis.Int J Mol Sci. 2024 Mar 15;25(6):3333. doi: 10.3390/ijms25063333. Int J Mol Sci. 2024. PMID: 38542307 Free PMC article. Review.
-
Get to Know Your Neighbors: Characterization of Close Bacillus anthracis Isolates and Toxin Profile Diversity in the Bacillus cereus Group.Microorganisms. 2023 Nov 7;11(11):2721. doi: 10.3390/microorganisms11112721. Microorganisms. 2023. PMID: 38004733 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials